期刊文献+

Dppz配体10,13-位由芳香基取代的新型单核钌配合物的合成

Synthesis of novel mononuclear Ru(Ⅱ) complexes with 10,13-diaryl substituents on the dppz ligands
下载PDF
导出
摘要 目的本论文以1,10-邻菲罗啉(1,10-phenanthroline,phen)为辅助配体,在主配体联吡啶类(3,2-a:2'-3'-c)吩嗪[pyrido-(3,2-a:2',3'-c) phenazine,dppz]的10,13-位分别引入噻吩、苯并噻吩、呋喃及苯并呋喃,设计并合成出对应4种新型单核二-(1,10-邻菲罗啉)-吡啶类(3,2-a:2'-3'-c)吩嗪合钌(Ⅱ)衍生物。方法首先通过Suzuki偶联反应得到4种苯并噻二唑中间体,然后经Co Cl2催化、Na BH4还原得到邻苯二胺类化合物,再经缩合反应得到对应的目标配合物。结果苯并噻二唑中间体及对应的4种目标配合物通过磁共振氢谱、碳谱及高分辨质谱表征,紫外-可见吸收光谱进一步验证了目标配合物结构的正确性。结论本论文通过多步反应合成出以1,10-邻菲罗啉为辅助配体,主配体dppz的10,13-位分别含有噻吩、苯并噻吩、呋喃及苯并呋喃的4种新型单核多吡啶钌配合物。紫外-可见吸收光谱实验表明尽管4种芳香取代基结构有差异,对应苯并噻二唑中间体和钌配合物的吸收光谱相似。 Objective Four new ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10,13-position substituted[pyrido-(3,2-a:2’,3’-c)phenazine,dppz]major ligands including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole will be designed and synthesized.Methods Target complexes were made by condensation reaction of ruthenium complex with the appropriate 3,6-diaryl substituted benzene-1,2-diamine.The latter 3,6-diaryl substituted benzene-1,2-diamine was obtained by a Suzuki-coupling reaction,and subsequently by reduction with Na BH4 under catalysis of Co Cl2.Results Benzothiadiazole intermediates and corresponding target complexes are well characterized by1 H nuclear magnetic resonance(NMR),13 C NMR and TOF-Mass.UV-vis absorption spectra of all ruthenium complexes further verify the structures of the target complexes.Conclusion In this paper,we have synthesized four mononuclear ruthenium complexes with 1,10-phenanthroline ancillary ligand and 10,13-diaryl including thiophenyl,furanyl,[2-benzo(b)thienyl]-2,1,3-benzothiadiazole and[2-benzo(b)furanyl]-2,1,3-benzothiadiazole,substituted dppz as major ligand through multiple steps.Both four 4,7-position substituted 2,1,3-benzothiadiazole intermediates and corresponding ruthenium complexes exhibit substantially similar absorption spectra despite the structural difference.
作者 李敏娜 Li Minna(Department of Chemical Biology,School of Pharmaceutical Sciences,Capital Medical University,Beijing 100069,China)
出处 《首都医科大学学报》 CAS 北大核心 2019年第2期263-268,共6页 Journal of Capital Medical University
基金 国家自然科学基金青年基金(21708027) 北京市科技计划面上项目(SQKM201210025006) 首都医科大学自然科学基金(2015ZR17)~~
关键词 钌配合物 联吡啶类(3 2-a’-3’-c)吩嗪配体 10 13-芳香基取代 ruthenium complexes pyrido-(3,2-a:2’,3’-c)phenazine ligand 10,13-diaryl substituted
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部